Chicago Barn to Wire
Home | News | Bloggers | Forums | Resources | Links | Marketplace | Gallery | Contact Us | Search

November 30, 2015, 11:44:49 PM *
Welcome, Guest. Please login or register.

Login with username, password and session length
News: If you don't remember your password, email me.

New  registration procedures -- Some ISPs have been bouncing the verification emails.  Please email me to be activated or if you have any problems.  Click Contact Us above.
   Home   Help Search Login Register  
Pages: [1]   Go Down
Author Topic: Langley Appoints Medication Advisory Committee  (Read 692 times)
Hero Member
Posts: 6853

« on: November 07, 2013, 11:07:43 AM »

In order to develop comprehensive proposals on the use of therapeutic medications and recommended penalties for violations in harness racing, President Phil Langley has appointed a diverse panel of experts to a new United States Trotting Association (USTA) medication advisory committee.
“Recognizing that some of the fault was that the USTA lacked sufficient scientific representation on the Racing Medication and Testing Consortium (RMTC),” said USTA President Phil Langley, “I have appointed a widely representative advisory committee to guide us in future medication proposals.”
The members of the USTA medication advisory committee are: eminent researchers Dr. George Maylin and Dr. Thomas Tobin; practicing veterinarians Dr. Jay Baldwin, Dr. Janet Durso and Dr. William Moffett; trainers Mark Ford, Sam Beegle, Ray Schnittker and David McCaffrey;  racing commissioners Bob Schmitz and Alan Leavitt;  attorneys Joe Faraldo and Chris Wittstruck;  racing investigator Brice Cote;  Hambletonian Society President and CEO Tom Charters; and Phil Langley, Mike Tanner, and T.C. Lane from the USTA.
As has been widely reported during the past few weeks, the USTA has struggled with acceptance of some of the RMTC and Association of Racing Commissoners International (RCI) proposed uniform medication rules – especially those regarding clenbuterol and corticosteroids.
“Under these proposed rules, both medications would become virtually useless in harness racing,” said USTA President Phil Langley.  “We are hopeful that after much discussion with RMTC and with testimony before racing commissions, some adjustments will be forthcoming.”
The USTA has already been working with the Pennsylvania horsemen groups to commission Dr. Larry Soma and Dr. Mary Robinson to conduct research on items like EPO, extracorporeal shock wave therapy and some of the unknown drugs that most threaten the integrity of harness racing.  Their research also is pursuing alternatives to clenbuterol and the adjustment of threshold levels that can be utilized with Standardbreds.
Dan Leary
Director of Marketing and Communications
Report to moderator   Logged
Pages: [1]   Go Up
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines Valid XHTML 1.0! Valid CSS!
Page created in 0.061 seconds with 18 queries.

Upcoming events
Triple Crown
Illinois Derby
Horse slaughter in IL
Racing TV schedule
News Updates

Galloping Out

Previous stories

Chicago Sun-Times
Chicago Tribune
Daily Racing Form
Thoroughbred Times
Harness Link
Illinois Racing Board



Arlington Million
Triple Crown
Illinois Derby


Breeders' Cup
Arlington Million
Triple Crown
Illinois Derby


Breeders' Cup
Hawthorne Gold Cup
Arlington Million
Triple Crown
Illinois Derby

More ebay items


Home | News Updates | Bloggers | Forums | Search
Resources | Links | Marketplace | Gallery | Advertising | Contact Us

Copyright © 2000-2015 Chicago Barn to Wire. All rights reserved.
Privacy policy